Abstract
Although immune checkpoint blockade (ICB) therapies have shown clinical benefit, ICBs exert limited effects on most “immune‐cold” solid tumors, i.e., tumors with low immune infiltration. Photothermal immunotherapy (PTIT) converts “cold” tumors into “hot” tumors, thereby enhancing immune responses and improving ICB efficacy. Hence, developing a strategy that can integrate PTIT and ICB treatment is desirable. In this study, we designed a unique carrier‐free PSP@IR‐CF 3 nanofiber, self‐assembled from the programmed death‐ligand 1 (PD‐L1) targeting immune‐peptide NTGYFYGDQ (PSP) and a PTIT agent (IR‐CF 3 ). The nanofibers enable precise tumor targeting and immune checkpoint inhibition by specifically binding to PD‐L1 on the tumor cell surface, also providing an NIR‐mediated photothermal effect. Combining PSP@IR‐CF 3 nanofibers with NIR induced mild PTIT, which effectively activated the tumor immune microenvironment and suppressed tumor growth with lower immunotoxicity. Additionally, we identified activation of the heat shock protein 70 (HSP70) /AKT/mTOR axis following PTIT, suggesting a potential role in post‐treatment tumor survival and recurrence. By incorporating the mTOR inhibitor rapamycin, the combination treatment further enhanced therapeutic efficacy and reduced tumor recurrence.
Funding Information
  • Natural Science Foundation of Beijing Municipality (7254548)
  • Natural Science Foundation of Beijing Municipality (7252292)
  • Natural Science Foundation of Beijing Municipality (7244524)
  • National Natural Science Foundation of China (U24A20731)
  • National Natural Science Foundation of China (81227901)
  • National Natural Science Foundation of China (81930053)
  • National Natural Science Foundation of China (62027901)
  • National Natural Science Foundation of China (32101153)
  • National Natural Science Foundation of China (82502418)
  • Beijing Nova Program (20240484650)
  • Natural Science Foundation of Shandong Province (ZR2025LZL007)

This publication has 55 references indexed in Scilit: